Effectiveness and safety of secukinumab in patients with moderate‐severe psoriasis: A multicenter real‐life study
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.14044
Abstract: This study assessed the effectiveness and safety of secukinumab in patients with moderate‐severe psoriasis vulgaris in a real‐world setting. A total of 120 patients (35.8% women; mean age 49.8 years) were enrolled. Mean PASI significantly decreased… read more here.
Keywords: effectiveness safety; study; safety secukinumab; secukinumab patients ... See more keywords
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
Sign Up to like & getrecommendations! Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2022-002303
Abstract: Objectives To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations. Methods In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and axial… read more here.
Keywords: response; secukinumab patients; response secukinumab; axial manifestations ... See more keywords